AKAN Akanda Corp

56

Healthcare [ 11/13 ] | Drug Manufacturers - Specialty & Generic [ 59/159 ]

NASDAQ | Common Stock

Price
$0.0915
Increased by +2.01%
Dollar Volume (20D)
1.32 M
ADR%
26.06
Shares Float
2.21 M
Shares Outstanding
11.93 M
Shares Short
1.08 M
Market Cap.
1.07 M
Beta
1.61
Price / Earnings
N/A
20D Range
0.09 0.27
50D Range
0.09 0.32
200D Range
0.09 1.05
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
May 2, 22 -0.5 -
Mar 16, 22 0 -
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 22 N/A
Decreased by -100%
 N/A
Increased by +100%
 - -
Sep 30, 22 N/A
Decreased by -100%
 N/A
Increased by +100%
 - -
Jun 30, 22 N/A
Decreased by -100%
 N/A
Decreased by -100%
 - -
Mar 31, 22 24.07 K - -2.81 M -
Decreased by -11.68 K%
-
Dec 31, 21 24.07 K - -2.81 M -
Decreased by -11.68 K%
-
Sep 30, 21 13.42 K - -4.74 M -
Decreased by -35.31 K%
-
Dec 31, 20 274 - 585.42 K -
Increased by +213.66 K%
-
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.